About Us

The Corsano Solution enables continuous multi-parameter monitoring for all patients in general wards. Extending visibility beyond the ICU to thousands of beds is a transformational step for patient safety and quality of care. Together with hostpital’s clinical teams, we demonstrate how CardioWatch continuous data, combined with predictive algorithms and EMR integration, can reduce adverse events, support nursing staff, and ultimately save lives.” said Peter Stas, Chief Executive Officer of Corsano Health.

Building a data-driven, predictive care model

Corsano’s wearable devices are designed for continuous, comfortable use in hospital and post-discharge settings. The system provides secure, near real-time data streaming to Corsano’s cloud platform and onward to EMR and clinical systems, enabling:

• Automated early warning scores and predictive risk algorithms
• Centralized monitoring and alerting beyond ICUs and high-care units
• Reduced manual vital-sign documentation burden for nursing staff
• High-resolution datasets that can power clinical research and AI-driven innovation

Our History

In the heart of Geneva, entrepreneurs Peter & Aletta Stas laid the foundation for their global watch company, Frederique Constant. From the outset, their entrepreneurial spirit was intertwined with a commitment to societal well-being. Their passion found purpose as they actively engaged with charitable organizations dedicated to combating heart disease.

The turning point arrived when the acquiring entity of Frederique Constant expressed disinterest in the Smartwatch division. Peter and Aletta seized the opportunity to spin this division off into a separate company to develop medical technology. Thus, Corsano Health emerged in the field of continuous patient monitoring with wearables to advance healthcare. The Corsano brandname is derived from in corpore sano (in a healthy body).

Fast forward six years, and the Corsano Solution has been utilized in over 200 rigorous clinical studies. Groundbreaking research is currently being conducted in therapeutic fields such as Arrhythmias, Hypertension, and Immune Oncology using the system. For Peter and Aletta, their dream of making a transformative impact on healthcare has transcended aspiration to drive the company.

Recently, Corsano has start to roll out the Corsano Solution in hospital and hospital-to-home settings delivering multi-parameter monitoring for general ward patients to enhance quality of care, safety and clinical outcomes.

What Differentiates Corsano Health

Corsano Health B.V. achieved certification as a medical device manufacturer according to the ISO 13485 norm under the new MDR regulations in November 2021. In addition, the first product CardioWatch 287 achieved CE certification as a medical product under the new MDR regulation. Clinical accuracy is paramount for us. In addition to third parties’ algorithms, we run our proprietary algorithms to realize superior data accuracy. Corsano technology has been clinically validated in major academic hospitals. The bracelet is manufactured under ISO 13485 and CE-MDR compliance. FDA cleared the Corsano CardioWatch 287-2 System in 2024.

Device and platform is EU-MDR certified and FDA 510(k) Cleared. Validated and proven with clinical trial data. QMS enables to add sensors, algorithms to Medical platform. Corsano’s medical-grade wearable devices and cloud platform, seamlessly integrate into Electronic Medical Record (EMR) environments, to support clinical workflows, nursing efficiency and data-driven care.

35 years experience, ergonomic product, choice of materials, craftsmanship, battery life of 7-15 days, ergonomic and aesthetic designs that stimulate continuous wear. CardioWatch bracelets combine an intuitive, user-friendly design with exceptional wearing comfort and long battery life, delivering truly effortless continuous monitoring.

Supply chain wearables, deep relationships with suppliers, Swiss quality, agility to rapidly develop next generations. Emerging as a spin-out from Frederique Constant, which produced hundreds of thousands of fine luxury watches, Corsano brings proven supply-chain experience in high-precision, high-volume manufacturing.

The CardioWatch monitor offers flexibility to set data collection intervals by 30 seconds, minute and 5 minutes.

Raw data available at 25Hz, 64Hz and 128 Hz.

We measure Heart Rate, RR intervals, Breathing Rate, A-Fib detection, SpO2, Core Body Temperature, ECG, Blood Pressure, Activity and Sleep.